Skip to content

The effect of ultrasonic nebulization with warming and oxygen on patients with acute exacerbation of chronic obstructive pulmonary disease

The effect of ultrasonic nebulization with warming and oxygen on patients with acute exacerbation of chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003330
Enrollment
Unknown
Registered
2013-07-15
Start date
2010-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

oxygen-driven nebulization:oxygen-driven nebulization
classical ultrasonic nebulization:classical ultrasonic nebulization
ultrasonic nebulization with warming and oxygen:ultrasonic nebulization with warming and oxygen

Sponsors

First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: Between December 2010 and November 2011 hospitalized patients with AECOPD diagnosed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2009 at the First Affiliated Hospital of Guangzhou Medical University, will be recruited for the present study.

Exclusion criteria

Exclusion criteria: (1) concomitant bronchial asthma or hemoptysis; (2) a history of chest surgery or active bleeding during the previous 3 months; (3) inability to complete a pulmonary function test (PFT) due to certain conditions (pulmonary bullae, dyspnea, pulmonary embolism necessitating bed rest, or coronary heart disease), and (4) infectious diseases, mental disorders, severe cognitive impairment, or other conditions that may prevent the patient from cooperating with the investigators.

Design outcomes

Secondary

MeasureTime frame
nebulization rate;

Primary

MeasureTime frame
frequency of cough;time to first expectoration;FVC;FEV1;PEF;Peripheral oxygen saturation (SpO2);heart rate (HR);respiratory rate (RR);dyspnea;chest tightness;patient comfort about the nebulization;Temperature of mouthpiece aerosol;

Countries

China

Contacts

Public ContactZeguang Zheng
13503034012@139.com+86 13503034012

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026